The page is the record's research on the issuer — no analyst, no rating, no view.

Solasia Pharma K.K. (4597) — research page

JP · jp-cm-kg/TSE-GROWTH/4597 · as of 2026-11-06

Identity and listing

The issuer is Solasia Pharma K.K., listed on the Growth Market, ticker 4597, ISIN JP3436500007, LEI 529900A8W8K4LULTG564. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.

fieldvaluesource · read date
nameSolasia Pharma K.K.source · 2026-11-06
exchangeGrowth Marketsource · 2026-11-06
ticker4597source · 2026-11-06
ISINJP3436500007source · 2026-11-06
LEI529900A8W8K4LULTG564source · 2026-11-08
security typeCorporatesource · 2026-11-06
segmentnot on the record
sector3250 Pharmaceuticalsource · 2026-11-06
jurisdictionJapan (EDINET domestic filer)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 6 filings on 3 filing days in the window 2025-11-06 to 2026-11-06, comprising 1 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 71.0 days. The latest filing is dated 2026-08-13, a regulatory filing, and is 85 days before the record date 2026-11-06. The Growth Market median is 42 days cadence, 8.0 filings and 85.0 days latency across 598 issuers. The 3250 Pharmaceutical median is 49.5 days cadence, 8.0 filings and 85.0 days latency across 80 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer67185
exchange median: Growth Market (598 issuers)84285
sector median: 3250 Pharmaceutical (80 issuers)849.585
datetypecategoryfiling
2026-08-13regulatory_filing135確認書
2026-08-13results半期報告書 (half-year report)半期報告書-第19期(2026/01/01-2026/12/31)
2026-03-27ad_hoc臨時報告書 (extraordinary report)臨時報告書
2026-03-24regulatory_filing235内部統制報告書-第18期(2025/01/01-2025/12/31)
2026-03-24regulatory_filing135確認書

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is 三優監査法人, with its location not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.

Orderability

For the client category Qualified Institutional Investors, the signal is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Qualified Institutional Investorsnot determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope

rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 2 research houses: SBI Securities Co., Ltd. and Pathology Associates K.K.

research houseanalystsource · read date
SBI Securities Co., Ltd.Ryuta Kawamuraissuer page · 2026-11-12
Pathology Associates K.K.Dion Stéfan Büchner M.D., FCAPissuer page · 2026-11-12

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The issuer's years are not sealed. The market's vintage is not sealed, and the market's earliest sealed date is not on the record. The live record began not on the record.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
10.3
https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4597 (the disclosure lines)
10.6
https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
10.7
https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XT68 (the auditor)
10.8
https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
10.9
https://solasia.co.jp/en/ir/stockinfo/analyst-coverage.html (coverage)
10.10
https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4597 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"JP3436500007"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:afc24bcd6bd8c024.